Artificial Intelligence in Acute Coronary Syndrome Prediction: Evidence, Mechanisms, and Clinical Implications

Abstract

Acute coronary syndrome (ACS) remains a leading cause of morbidity and mortality worldwide, creating an urgent need for accurate and timely risk stratification. Artificial Intelligence (AI), leveraging machine learning and deep learning algorithms, is increasingly being utilized to enhance ACS prediction, improve diagnostic accuracy, and facilitate informed clinical decisions. This review synthesizes current evidence on AI applications in ACS prediction, highlights underlying mechanisms, evaluates clinical utility, and discusses practical implications for healthcare professionals. Emphasis is placed on the integration of AI with traditional risk models, the interpretation of complex data, and the potential to personalize patient care while addressing inherent limitations and future directions in this emerging field.

Introduction

Acute coronary syndrome encompasses a spectrum of urgent cardiac events, including unstable angina and myocardial infarction, resulting from acute myocardial ischemia. Traditional diagnostic and risk stratification tools, although fundamental, often fall short in predictive precision, especially in heterogeneous clinical presentations. The advent of AI offers a transformative approach by harnessing vast, complex datasets ranging from electronic health records to imaging and genomics to enhance risk prediction models. Recent advances in computational power and algorithmic sophistication have enabled the development of AI systems that can identify subtle patterns and interactions not apparent to clinicians, thus paving the way for more individualized and proactive ACS management.

Epidemiology / Disease Burden

ACS continues to present a significant global health challenge, accounting for millions of emergency visits and hospital admissions annually. Despite advances in primary prevention and therapeutic interventions, the incidence of ACS remains high, particularly among aging populations and individuals with multiple comorbidities. The disease burden is compounded by delays in diagnosis, under-recognition of atypical presentations, and variability in access to care. Early and accurate prediction of ACS events is paramount to reducing mortality, minimizing complications, and optimizing resource allocation. AI-driven predictive models, by augmenting traditional risk assessment tools, have the potential to address critical gaps in early detection and timely intervention.

Pathophysiology

The pathophysiology of ACS primarily involves the disruption of atherosclerotic plaques within coronary arteries, leading to thrombus formation and subsequent myocardial ischemia or infarction. The complex interplay of endothelial dysfunction, inflammation, lipid accumulation, and hemodynamic stress underpins plaque vulnerability. AI algorithms, particularly those employing deep learning, can analyze multidimensional datasets including biochemical markers, imaging features, and clinical variables to discern patterns indicative of pathophysiological shifts preceding acute events. These insights enable earlier identification of high-risk individuals, even before overt clinical manifestations, thereby supporting primary and secondary prevention strategies.

Risk Factors

Traditional risk factors for ACS such as hypertension, diabetes, dyslipidemia, smoking, family history, and sedentary lifestyle remain central to risk stratification. However, emerging research highlights the significance of nontraditional factors, including genetic predispositions, psychosocial stressors, and inflammatory biomarkers. AI excels in integrating and weighting these diverse variables, offering dynamic risk assessment tailored to individual patient profiles. By continuously learning from new data, AI systems can update risk calculations in real time, thus reflecting changes in patient status and emerging evidence from ongoing research.

Clinical Features

ACS clinical presentation is notoriously variable, ranging from classic chest pain to atypical symptoms such as dyspnea, fatigue, or silent ischemia particularly in women, elderly, and diabetic patients. AI-powered tools, including natural language processing and pattern recognition algorithms, can analyze structured and unstructured clinical data to detect subtle symptom clusters and atypical presentations that may be overlooked by standard assessment. Such approaches enhance early recognition, reduce diagnostic uncertainty, and support appropriate triage in emergency settings.

Diagnosis

Accurate diagnosis of ACS hinges on the integration of clinical assessment, electrocardiography (ECG), cardiac biomarkers, and imaging modalities. AI has demonstrated superior performance in ECG interpretation, with convolutional neural networks capable of detecting ischemic changes, arrhythmias, and subtle waveform abnormalities that may elude human readers. Additionally, AI-driven analysis of troponin kinetics, echocardiography, and coronary CT angiography enables comprehensive, rapid, and reproducible diagnostic evaluations, thereby facilitating timely initiation of evidence-based therapies.

Treatment & Management

The management of ACS involves prompt reperfusion strategies, antithrombotic therapy, and secondary prevention measures. AI applications extend to treatment optimization by predicting individual responses to pharmacologic agents, risk of bleeding, and likelihood of adverse events. Clinical decision support systems utilizing AI can assist clinicians in selecting appropriate interventions, monitoring therapy adherence, and adjusting management plans based on dynamic changes in patient condition. Such personalization of care may lead to improved outcomes and reduced healthcare costs.

Recent Advances / Emerging Therapies

Recent years have witnessed the development of sophisticated AI models trained on multi-omic, imaging, and longitudinal clinical data. These models can predict near-term ACS events, identify patients at risk of stent thrombosis or restenosis, and even forecast readmissions post-discharge. Integration with wearable technologies and remote monitoring devices further expands the reach of AI, enabling continuous risk surveillance and early warning alerts. Novel research is exploring explainable AI frameworks to enhance transparency and clinician trust in algorithmic recommendations, addressing a key barrier to widespread clinical adoption.

Guideline Recommendations

Leading professional societies, including the American Heart Association and European Society of Cardiology, acknowledge the promise of AI in cardiovascular risk assessment and encourage its integration into clinical workflows where validated. However, they emphasize the need for rigorous prospective validation, transparency in model development, and consideration of ethical, legal, and data privacy issues. Guidelines advocate for multidisciplinary collaboration among clinicians, data scientists, and ethicists to ensure that AI deployment augments rather than replaces clinical judgment and patient-centered care.

Conclusion

AI represents a paradigm shift in the prediction and management of acute coronary syndrome, offering unprecedented opportunities for early detection, risk stratification, and personalized care. While substantial progress has been made, challenges remain regarding model interpretability, generalizability, and integration into existing healthcare systems. Ongoing research, robust validation, and interdisciplinary collaboration will be pivotal in realizing the full potential of AI to reduce the global burden of ACS and improve patient outcomes.